Similar to the case of European individuals with Lynch syndrome [38], recent clinic-based observations have reported deleterious mutations that disrupt the function of the MMR gene product (MLH1 (61%), MSH2 (21%), PMS2 (12%), and MSH6 (6%)) in an African American population with Lynch syndrome [39]. The gene discussed is MSH6; the disease is Lynch syndrome.